Rectal Cancer Trial On Defunctioning Stoma
Completed
- Conditions
- Rectal Cancer
- Registration Number
- NCT00636948
- Lead Sponsor
- Rectal Cancer Trial on Defunctioning Stoma Study Group
- Brief Summary
The hypothesis of the present trial was that the use of a defunctioning loop stoma reduces the rate of symptomatic anastomotic leakage from 15% to 7.5% after low anterior resection of the rectum for cancer.
- Detailed Description
The assumption that a defunctioning loop stoma reduces symptomatic anastomotic leakage from 15% to 7.5%, with a level of statistical significance of 5% and a statistical power of 80%, requires randomization of 220 patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 234
Inclusion Criteria
- Absence of intraoperative adverse events according to the study protocol and the operating surgeon.
Exclusion Criteria
- Presence of intraoperative adverse events according to the study protocol and the operating surgeon.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptomatic anastomotic leakage following low anterior resection of the rectum for cancer with and without a defunctioning stoma. Anorectal function after one and five years without defunctioning stoma. 30 days, one year and five years.
- Secondary Outcome Measures
Name Time Method Reoperation within 30 days of initial surgery. 30 days
Trial Locations
- Locations (1)
Department of Surgery, Linköping University Hospital
🇸🇪Linköping, Sweden